Immusoft Corporation is programming human immune cells to produce therapeutics in the body.

Immusoft’s mission is the development of an exciting, new breakthrough platform for treating a variety of genetic diseases through a process called Immune System Programming (ISP™).

Their technology enables the efficient insertion of genes encoding therapeutic proteins into patients’ immune cells (B cells / plasma cells).

More info